SCHEMBL4774239

SCHEMBL4774239

CO[C@H]1CCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1644988 1.00
SCHEMBL3569489 1.00
SCHEMBL16454010 0.92
SCHEMBL7625313 0.92
SCHEMBL9024964 0.92
SCHEMBL27965922 0.91 CHRNB2 (0.31)
SCHEMBL21900849 0.90 CYP1A2 (0.41)
SCHEMBL23747471 0.83
SCHEMBL28149301 0.83
SCHEMBL29290533 0.80 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108401647-B Weeding device 江苏大墩子银杏生物科技有限公司 2021-01-05 CN disclosed
CN-108496537-B Air-exhaust type wormwood harvesting equipment 江苏大墩子银杏生物科技有限公司 2021-01-01 CN disclosed
CN-105555761-A Novel biphenyl derivatives and process for preparing the same DONG A ST CO LTD 2016-05-04 CN disclosed
CN-105121436-A Novel pyridine derivatives HOFFMANN LA ROCHE 2015-12-02 CN disclosed
CN-104725397-A Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB 2015-06-24 CN disclosed
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 US disclosed
CN-104136435-A BROMODOMAIN INHIBITORS ABBVIE INC 2014-11-05 CN disclosed
CN-102232073-B Ssao activity inhibitor PROXIMAGEN LTD. (GB) 2014-10-29 CN disclosed
CN-102574825-A Thiazoles as cannabinoid receptor ligands ABBOTT LAB 2012-07-11 CN disclosed
US-8188089-B2 Tylophorine analogs as antitumor agents THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-05-29 US disclosed
CN-102232073-A New compounds I BIOVITRUM AB PUBL 2011-11-02 CN disclosed
CN-102216277-A Substituted benzamides as cannabinoid receptor ligands ABBOTT LAB 2011-10-12 CN disclosed
CN-102209716-A Novel compounds as cannabinoid receptor ligands ABBOTT LAB 2011-10-05 CN disclosed
CN-102036984-A Novel compounds as cannabinoid receptor ligands ABBOTT LAB 2011-04-27 CN disclosed
US-20090181948-A1 DIAMINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-07-16 US disclosed
US-20080300254-A1 Tylophorine Analogs as Antitumor Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 EP disclosed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 EP disclosed
CN-1571774-A Pyrimidinones as melanin concentrating hormone receptor 1 SMITHKLINE BEECHAM PLC (GB) 2005-01-26 CN disclosed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 WO disclosed